Vaccine Shows Promise In Stopping Plaque Buildup in Arteries
Chinese researchers have developed a “cocktail” nanovaccine to prevent plaque from building up in the arteries, an underlying factor in heart disease, which is the leading cause of death worldwide.
Aspirin May Prevent Metastasis of Cancer
Scientists at the University of Cambridge, who have been investigating how certain common medications might hold back the movement of cancer cells, have found that daily low-dose aspirin use could curb the spread of certain cancers, including breast and prostate tumors.
COVID-19 May Increase Kawasaki Disease Risk
A recent study found there is significantly higher intravenous immune globulin (IVIG) resistance among children who contracted COVID-19 before developing Kawasaki disease (KD).
GSK’s Penmenvy Meningococcal Vaccine Approved by FDA
GSK’s Penmenvy (meningococcal groups A, B, C, W and Y vaccine) has been approved by the U.S. Food and Drug Administration (FDA) for use in individuals aged 10 through 25 years.
Diagnosing and Treating Lyme Disease
Lyme disease is a rare disease that can cause long-term damage thanks to delayed and missed diagnoses — but it may soon have a vaccine.
Lyme Disease: A Physician’s Perspective
Kristopher Paolino, MD, is an assistant professor of medicine and assistant professor of microbiology and immunology at Upstate University Hospital in Syracuse, N.Y. He previously worked for the Walter Reed Army Medical Center and the Walter Reed Army Institute of Research in Washington, D.C. His research interests include vaccine development, Lyme disease, neglected tropical diseases and malaria.
Lyme Disease: A Patient’s Perspective
A tick bite changed Joleen Larsen’s life.
Study Reveals Best Time to Get RSV Vaccine During Pregnancy
New research led by investigators at Mass General Brigham suggests vaccination closer to 32 weeks of pregnancy, rather than the current guidelines of between 32 and 36 weeks, will better protect pregnant women’s newborns against respiratory syncitial virus (RSV).
Study Finds Link Between COVID-19 and Autoimmunity
A population-based study conducted by researchers from the Republic of Korea found a significantly higher risk of developing autoimmune and autoinflammatory conditions, such as rheumatoid arthritis (RA), lupus, Crohn’s disease, and alopecia, among individuals who had COVID-19, with risks particularly elevated for those with severe cases, Delta variant infections and those who were unvaccinated.
IVIG Reduces Symptom Severity for AGID
A new study indicates intravenous immun globulin (IVIG) therapy can reduce symptom severity for patients with autoimmune gastrointestinal dysmotility (AGID), also known as gastroparesis.
